Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

UPM establishes sustainable wood delivery option for its Leuna biorefinery, partnering with DB Cargo

UPM Leuna wood chips [UPM Leuna wood chips] UPM Leuna wood chips UPM Leuna wood rail testing [UPM Leuna wood rail testing] UPM Leuna wood rail testing (UPM, Helsinki, 14 March at 10:00 EET) – UPM Biochemicals  announced another important milestone in the development of the world’s first biorefinery in Leuna, Germany. In partnership with DB Cargo,  the first deliveries of wood have now been made to Leuna by rail, establishing and testing the direct rail link to the Leuna operations’ wood yard. This will

Internet Vikings Receives License as Online Gaming Service Provider in Connecticut

Internet Vikings , a leader in providing licensed in-state hosting solutions, announces its entry into Connecticut, offering its services to the online gaming industry. This expansion marks another achievement in the company's commitment to nationwide coverage, bringing its premium hosting solutions to a total of 24 states across the U.S. Connecticut made history in October 2021 by becoming the 6th state to launch legal online gambling. The collaborative effort between the state's tribes and gaming providers laid the foundation for an advancing

Everfuel A/S – Submission of proposals for AGM agenda 2024

Herning, Denmark, 14 March 2024 – Everfuel invites shareholders to submit proposals for agenda topics for the annual general meeting (AGM) 2024. On 18 April 2024 at 09.00 CET, Everfuel A/S will conduct the AGM 2024 for shareholders. Shareholders who wish to submit proposals for specific topics to be included in the agenda are encouraged to send their requests to the Director of Investor Relations and Communication, Mads T. Mortensen, no later than 28 March 2024 at 11:59 CET, via the contact information provided below. For additional information, please contact Mads T. Mortensen,

BioStock: Dicot’s phase I study fully recruited

Dicot continues to stay on schedule in its clinical phase I study. In January, the company, which is developing the next generation of potency drugs, was able to make a first positive data reading from the study, and now the last participant in the trial has been recruited.Read the full article at biostock.se : https://www.biostock.se/en/2024/03/dicots-phase-i-study-fully-recruited/ This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se

NextCell establishes QVance to meet the Nordic’s need for quality analytics

NextCell Pharma AB ("NextCell" or the "Company") today announces that it has formed a subsidiary company specialising in quality control analytics. QVance’s launch is a strategic addition for NextCell as the company grows its presence in the advanced therapy market. QVance will specialise in quality analyses for advanced therapeutic companies, including NextCell, in the growing cell and gene therapy market. QVance will address a large gap in the Nordic region, where there is a significant lack of local providers in this area.The Advanced Therapies Medicinal Product (ATMP) market is growing

Kongsberg Automotive wins a new contract worth approximately EUR 40 million in estimated lifetime revenue for a product used in electric vehicles

Zurich, March 14, 2024: Kongsberg Automotive has won a contract worth approximately EUR 40 million in estimated lifetime revenue for a new rotary actuator used in electric vehicles. The actuator’s main functions are decoupling of an electric motor and park lock. KA’s brand new product offers premium performance in compact packaging for electric vehicle transmissions and drive units. The start of production is scheduled for 2027. The actuator will be developed in Mullsjo, Sweden, in collaboration with KA’s plant in Shawinigan, Canada, and produced and supplied from our Vrable, Slovakia

Last day of trading with warrants of series TO3 in Cereno Scientific is today, March 14, 2024

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES, AUSTRALIA, CANADA, NEW ZEALAND, HONG KONG, JAPAN, SINGAPORE, SOUTH AFRICA, SOUTH KOREA, RUSSIA, BELARUS OR ANY OTHER JURISDICTION WHERE SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL OR WOULD REQUIRE REGISTRATION OR ANY OTHER MEASURES. PLEASE REFER TO IMPORTANT INFORMATION AT THE END OF THE PRESS RELEASE. Today, March 14, 2024, is the last day of trading with the warrants of series TO3 in Cereno Scientific AB (publ) (“Cereno” or the “Company”). The exercise period

Halton Healthcare selects Sectra’s cloud SaaS to optimize enterprise imaging workflows and strengthen security

Linköping, Sweden and Mississauga, ON – March 14, 2024 – International medical imaging IT and cybersecurity company Sectra  (STO: SECT B) will provide enterprise imaging in the cloud through its subscription model, Sectra One Cloud, to Halton Healthcare in Canada. The fully managed cloud service will enable the healthcare provider to streamline operations, consolidate IT systems maintenance, reinforce data security, and scale their use of the solution as needed for improved patient care.“In selecting a vendor, our top priority was to find a robust solution with peak

The Nomination Committees’ proposal for the Annual General Meeting 2024 of Attendo (including motivated opinion)

Description of the Nomination Committee’s work ahead of the Annual General Meeting The Annual General Meeting 2023 of Attendo (the “Company”) elected the following members of the Nomination Committee: Peter Hofvenstam (nominated by Nordstjernan), Anssi Soila (nominated by Pertti Karjalainen) and Niklas Antman (nominated by Inventive), with Peter Hofvenstam as Chair. The Nomination Committee has, in accordance with the instructions adopted by the Annual General Meeting 2020 and the Swedish Corporate Governance Code, been appointed to prepare the following proposals for the Company’s

DNB's Annual Report for 2023 is published today

The DNB Group's Annual Report, including Sustainability report and Pillar 3 report for 2023, are published today on DNB's website ir.dnb.no. For further information: Investor contacts:Rune Helland, Head of Investor Relations, tel. (+47) 23 26 84 00 / (+47) 977 13 250Thor Tellefsen, Head of Long-Term Funding, tel. (+47) 915 44 385 Media contact:Øystein Kløvstad Langberg, Executive Vice President of Communications, tel: (+47) 98 04 88 25 This information is subject to the disclosure requirements according to Section 5-12 of the Norwegian Securities Trading Act.

AstraZeneca to acquire Amolyt

14 March, 2024 AstraZeneca to acquire Amolyt Pharma,expanding late-stage rare disease pipeline Amolyt development portfolio includes Phase III asset with potential to address significant unmet need in patients with chronic hypoparathyroidism Acquisition to further expand the Alexion, AstraZeneca Rare Disease pipeline beyond complement inhibition, building on company's success in bone metabolism and opportunity in rare endocrinology AstraZeneca announced that it has entered into a definitive agreement to acquire Amolyt Pharma, a clinical-stage biotechnology company focused on

BII and Finnfund continue their support to women-led micro-enterprises in Pakistan through Kashf Foundation

Today, both British International Investment (BII), the UK’s development finance institution and impact investor, and Finnfund announced their continuing support to Kashf Foundation (Kashf), one of the leading microfinance institutions in Pakistan. BII has committed $15 million US dollars while Finnfund has committed $10 million US dollars as follow on investments. In 2021, Finnfund and BII made their initial investment in Kashf . Since then, Kashf has

CYBER1 - Strong end of 2023 - Mangold Insight Analysis

Mangold updates Cyber Security 1 ("CYBER1") after the fourth quarter of 2023. Revenue increased to EUR 18.8 (16.2) million in the fourth quarter, corresponding to growth of around 16 percent. At the same time, the gross margin improved to 25 (20) percent during the quarter. The EBITDA amounted to approximately EUR 1.4 (-0.5) million, which is a significant improvement on the same period last year. The EBITDA margin amounted to 7.3 percent, which was a strong close in 2023. For the full year, the EBITDA was in line with our estimate and the EBITDA margin was 1.2 percent. However, the result

AFRY implements cable planning for SuedOstLink in Germany

The SuedOstLink is a key grid expansion project for expediting Germany’s energy transition. AFRY has been appointed by the transmission system operator 50Hertz as technical advisor for the cable planning.First introduced in the Federal Requirements Plan in 2013, the SuedOstLink’s planning for the HVDC (extra-high voltage direct current) connection has been in process since 2016. It is primarily designed as an underground cable stretching around 540 kilometres from Wolmirstedt in Saxony-Anhalt to Landshut in Bavaria. Upon completion, the SuedOstLink will secure reliable transportation of

Faron to Host BEXMAB Webcast

Faron Pharmaceuticals Ltd.   (“Faron” or the “Company”)     Faron to Host Webcast to Discuss Latest Data from Phase 1 Part of the BEXMAB Study of Bexmarilimab   Press Release, March 14, 2024   TURKU, Finland / BOSTON, Massachusetts – March 14, 2024 – Faron Pharmaceuticals Ltd. (AIM: FARN, First North: FARON), a clinical-stage biopharmaceutical company pursuing a CLEVER approach to reprogramming myeloid cells to activate anti-tumor immunity in hematological and solid tumor microenvironments, today announces it will host a virtual BEXMAB update event on Tuesday,

Nurminen Logistics Plc’s Financial Statements, Board’s Report on Operations, Corporate Governance Statement and Remuneration Report for 2023 have been published

Nurminen Logistics Plc                    Stock Exchange Release         March 14, 2024 at 9.00. a.m. Nurminen Logistics Plc's Financial Statements, Board’s Report on Operations, and the Auditor's Report for 2023 have been published. The Financial Statements are published in accordance with the European Single Electronic Format (ESEF) reporting requirements. The Financials (including Financial Statements and Board's Report on Operations), Corporate Governance Statement, and Remuneration Report for 2023 have also been published today. The material is attached to this release and

ERV Nordic chooses Simplifai to automate their Claims Management

Oslo, Norway, 14 March: Simplifai, the Secure AI Automation provider, today announced that ERV Nordic has chosen the Simplifai AI Automation Platform to improve the way they handle their travel insurance claims.   With the goal of digitizing their travel insurance claims management and to become more cost-efficient, ERV Nordic selects Simplifai. Simplifai won against a number of international companies on ERV Nordic’s Request For Proposal (RFP), primarily on the speed Simplifai could get ERV Nordic to market, and the future-proof nature of the platform, including InsuranceGPT.

Genetic Analysis AS: Mandatory notification of trade – Primary Insider

OSLO, NORWAY – 14 March 2024: Genetic Analysis AS (“GA” or “the Company”) announces that a member of the management has bought GEAN-shares.Christina Casén, SVP Clinical & Medical Affairs of Genetic Analysis AS, has yesterday Wednesday 13.03.2024 bought 16.500 GEAN shares at an average price of 0,61 NOK per share. The shares were acquired on the Spotlight Stock Market. Following the transaction, Christina Casén owns 176.989 shares and 210.000 options.

Raisio plc: Notice to the Annual General Meeting

Raisio plc, Stock Exchange Release March 14 2024NOTICE OF RAISIO PLC’S ANNUAL GENERAL MEETING Raisio plc’s shareholders are invited to attend the Annual General Meeting to be held on Tuesday 9 April 2024 at 2 p.m. (EEST) in the Turku Fair Center at the address Messukentänkatu 9-13, 20210 Turku, Finland.  The reception of persons who have registered for the meeting and the distribution of voting tickets will commence at 1 p.m. (EEST) at the meeting venue. The shareholders can also exercise their voting rights by voting in advance. For further instructions, please refer to Section C 4.

InvestEU: NIB lends to zero and low carbon vessels with infrastructure in Norway

The Nordic Investment Bank (NIB) signs a 7-year loan to co-finance ferry and express boat operator Norled AS’ investments in zero and low carbon vessels and related land-based infrastructure in Norway during 2024-2030. The InvestEU programme supports the loan under NIBs Framework Operation Green Mobility and Transport approved by the Investment Committee.This NOK 500 million (EUR 43.4 million) loan will help Norled finance the extension of its low-carbon fleet. This is NIB’s first InvestEU loan in Norway. Norway is electrifying its transport network at a rapid pace, aiming to cut 50% of

Peab builds pilot platform facility for clean energy in Espoo

Peab has been commissioned to build a pilot platform facility for clean energy in Espoo. The customer is VTT Technical Research Centre of Finland Ltd. and the contract is worth EUR 19 million.The project entails building an addition to the VTT Bioruukki pilot center and updating the existing building. The pilot center is an innovation platform for new bio-based products and circular economy solutions. Bioruukki is one of Europe’s largest pilot facilities with open access and a combination of pilot-scale process development units and R&D services. The two story addition will house VTT’s

Half-year Report

14 March 2024   Strategic Equity Capital plc (‘SEC’)   Half Year Report and Financial Statements for the six months ended 31 December 2023   The Board of Strategic Equity Capital plc, the specialist alternative equity investment trust investing in high-quality, dynamic, UK smaller companies, is pleased to announce the Company’s results for the half-year ended 31 December 2023.   Highlights for the six months ended 31 December 2023 · NAV per share up 1.7%, despite challenging UK equity market conditions · Portfolio remains highly focused with 18 holdings and

Transaction in Own Shares

    14 March 2024 Vesuvius plc Share Buyback Programme – Transactions in Own Securities   Vesuvius plc (the "Company") announces that it has purchased the following number of its Ordinary Shares of 10p each from Jefferies International Limited (the “Broker”), pursuant to the terms of its Share Buyback Programme announced on 4 December 2023:   +---------------------------------------------------------------+----------+|Date of purchase: |13/03/2024|+-------------------------------------------------------------

STENOCARE A/S publishes Annual Report 2023

STENOCARE A/SNASDAQ FIRST NORTH GROWTH MARKET, DENMARKTICKER: STENO The Board of Directors and the Chief Executive Officer of STENOCARE A/S (“STENOCARE”) hereby publishes the annual report of the fiscal year 2023. The annual report including the auditor’s report is available as an attached file and on the website of STENOCARE and Nasdaq First North .Thomas Skovlund Schnegelsberg, CEO of STENOCARE, comments: ”2023 WAS ABOUT SECURING PRODUCT APPROVALS, SALES GROWTH AND

There are no items matching the current filter
There are no more items matching the current filter
Back to top